Fig. 8From: Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson’s diseaseEffects of combination treatment on dyskinesia induced by l -dopa. AIMs were measured 20 min after the administration of l -dopa (20 mg/kg). M: MPTP, K: KD5040, HL: high dose of l -dopa (20 mg/kg). *** p < 0.001 and * p < 0.05 vs. MPTP + l -dopa (20 mg/kg). AIMs: abnormal involuntary movementsBack to article page